EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 45 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $349,000 | -83.2% | 772,007 | 0.0% | 0.00% | -83.3% |
| Q1 2016 | $2,077,000 | -13.0% | 772,007 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $2,386,000 | +3.4% | 772,007 | +47.9% | 0.01% | 0.0% |
| Q3 2015 | $2,307,000 | -22.6% | 522,007 | 0.0% | 0.01% | -14.3% |
| Q2 2015 | $2,981,000 | -36.2% | 522,007 | 0.0% | 0.01% | -36.4% |
| Q1 2015 | $4,672,000 | +57.8% | 522,007 | 0.0% | 0.01% | +57.1% |
| Q4 2014 | $2,960,000 | -21.1% | 522,007 | 0.0% | 0.01% | -22.2% |
| Q3 2014 | $3,753,000 | – | 522,007 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|